Reporting results from a first-in-human phase I clinical trial, researchers at University of California San Diego School of Medicine have found that treatment with cirmtuzumab, an experimental monoclonal antibody-based drug, ...
Jun 1, 2018
0
46
One of the more promising biomarkers to measure biological aging is DNA methylation, an epigenetic modification that alters a specific sequence of DNA nucleotides known as CpG sites. Researchers have traditionally used epigenetic ...
Jan 10, 2022
0
7
Researchers at Karolinska Institutet and Kanazawa University in Japan have made a new discovery that could improve breast cancer treatments. The researchers studied cancer stem cells (CSCs), which can resist chemotherapy ...
Nov 24, 2023
0
74
Researchers in Oregon have engineered a material that replicates human bone tissue with an unprecedented level of precision, from its microscopic crystal structure to its biological activity. They are using it to explore ...
Aug 6, 2019
0
84
New insight into a gene that controls energy production in cancer stem cells could help in the search for a more effective treatment for glioblastoma. A McGill-led study published in Nature Communications reveals that suppressing ...
Aug 17, 2020
0
243
Targeted cancer therapies work by blocking a single oncogenic pathway to halt tumor growth. But because cancerous tumors have the unique ability to activate alternative pathways, they are often able to evade these therapies—and ...
Apr 13, 2015
0
107
Scientists from the Spanish National Cancer Research Centre (CNIO) have discovered a new strategy to fight cancer, which is very different from those described to date. Their work shows for the first time that telomeres—the ...
May 13, 2015
0
62
New UCLA research could help explain the link between a high-cholesterol diet and an elevated risk for colon cancer.
Jan 25, 2018
2
88
Scientists from an international consortium led by Dr. Eduard Batlle, head of the Colorectal Cancer laboratory at IRB Barcelona, ICREA researcher and group leader of CIBER de Cáncer (CIBERONC), together with the Dutch company ...
Apr 25, 2022
0
68
Researchers at Helmholtz Zentrum München describe how breast cancer cells challenged with a small-molecule inhibitor targeting specific invasive properties switch to an alternative mode-of-action, rendering them even more ...
Apr 27, 2016
0
56
